Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae
- 1 October 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 24 (4) , 509-521
- https://doi.org/10.1093/jac/24.4.509
Abstract
Five plasmid-mediated β-lactamases conferring a high level of resistance to ceftazidime were isolated from Klebsiella pneumoniae strains. These ceftazidimases (CAZ) differed in their isoelectric point (from 5·3 to 8·2) and were encoded by large selftransferable plasmids of 85 kb (CAZ-2, CAZ-3) or ≥ 150 kb (CAZ-1, CAZ-4, CAZ-5). The 85 kb plasmids seemed closely related to pCFF04 encoding CTX-1 enzyme and belonged to the same incompatibility group 7 or M. These β-lactamases hydrolysed all β-lactams with the exception of cephamycins and carbapenems. For CAZ-1, CAZ-2 and CAZ-3 producers, MICs of ceftazidime (32–256 mg/l) were higher than MICs of cefotaxime (0·12–2 mg/l) and aztreonam (1–16 mg/l). For the strains producing the β-lactamases CAZ-4 and CAZ-5, MICs of aztreonam were the highest ( ≥ 256 mg/l). The impaired activities of cephalosporins and monobactams were restored equally well by 2 mg/l of clavulanate, sulbactam and CL-298741 for CAZ-2 producing strains (wild type and transconjugant). Sulbactam (2 mg/l) had a lower protective effect than other inhibitors on ceftazidime for CAZ-1 and CAZ-3 producing K. pneumoniae. The protective effect of sulbactam (2 mg/l) was lower than that of the other inhibitors on all β-lactams for CAZ-4 and CAZ-5 producers. The enzymes CAZ-1, CAZ-2 and CAZ-3 derived from TEM β-lactamase whereas CAZ-4 and CAZ-5 derived from SHV-1 enzyme.Keywords
This publication has 9 references indexed in Scilit:
- Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1988
- Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1988
- Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJournal of Antimicrobial Chemotherapy, 1987
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987
- Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporinsInfection, 1987
- Molecular cloning and DNA homology of plasmid-mediated β-lactamase genesMolecular Genetics and Genomics, 1987
- Purification and biochemical properties of pitton's type 2 beta-lactamase (SHV 1)Annales de l'Institut Pasteur / Microbiologie, 1986
- Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1985